Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Clinical trial NCT00410462 · UNKNOWN
Trial details
- NCT number
- NCT00410462
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2008-09-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.